SignaCor

Seed
signacor.co.uk Biotech & Healthcare Belfast, United Kingdom
Total Funding Undisclosed
Latest Round Undisclosed Seed
Last Announced Mar 9, 2026
Investors Undisclosed
Decision Makers 3 Verified

About SignaCor

SignaCor is a clinical-stage biotech company exploring therapeutics for cardiac disorders, specifically hypertrophic cardiomyopathy.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Belfast, United Kingdom
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website signacor.co.uk
Domain Registered Date Oct 28, 2024

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Seed announced

  2. Milestone

    Website domain registered

    signacor.co.uk

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for SignaCor.

Funding History

1 Round
Seed equity · Mar 9, 2026
Undisclosed

Founders & Leadership

1

Chris Watson

Founder

Work email & phone locked Unlock →

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts